Lose Weight

October 26, 2009
Arena Pharma rises on new lorcaserin trial data
The Associated Press
In June, the San Diego company said lorcaserin met its key goals in the study by helping patients and keep it off. Arena stock rose 19 cents,
See all stories on this topic

Leave a Reply